In the sandbox: palliative care and hematologic malignancies.

Published

Journal Article

Palliative care specialists have had little involvement in the care of patients with hematologic malignancies. The reasons for this are not clear, because these patients certainly face a significant symptom burden, and many hematologic malignancies are either incurable or carry poor prognoses. For example, acute myeloid leukemia (AML) in patients over age 60 has a 5-year survival of less than 10%, akin to pancreatic cancer. Although most oncologists would agree with involving palliative care specialists in the case of advanced pancreatic cancer, few seem to consider this in the context of AML. Why should AML be any different?

Full Text

Duke Authors

Cited Authors

  • LeBlanc, TW

Published Date

  • February 2014

Published In

Volume / Issue

  • 12 / 2

Start / End Page

  • 44 - 45

PubMed ID

  • 24971402

Pubmed Central ID

  • 24971402

International Standard Serial Number (ISSN)

  • 2330-7749

Digital Object Identifier (DOI)

  • 10.12788/jcso.0012

Language

  • eng

Conference Location

  • United States